Credit Suisse’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.25M | Buy |
124,622
+5,575
| +5% | +$55.8K | ﹤0.01% | 2128 |
|
|
2023
Q4 | $486K | Buy |
119,047
+14,048
| +13% | +$57.3K | ﹤0.01% | 2737 |
|
|
2023
Q3 | $406K | Sell |
104,999
-15,091
| -13% | -$58.4K | ﹤0.01% | 2785 |
|
|
2023
Q2 | $716K | Buy |
120,090
+21,139
| +21% | +$126K | ﹤0.01% | 2589 |
|
|
2023
Q1 | $324K | Buy |
98,951
+9,461
| +11% | +$30.9K | ﹤0.01% | 2948 |
|
|
2022
Q4 | $353K | Buy |
89,490
+20,929
| +31% | +$82.7K | ﹤0.01% | 2936 |
|
|
2022
Q3 | $411K | Buy |
68,561
+9,082
| +15% | +$54.4K | ﹤0.01% | 2886 |
|
|
2022
Q2 | $382K | Buy |
59,479
+34,545
| +139% | +$222K | ﹤0.01% | 2995 |
|
|
2022
Q1 | $206K | Buy |
24,934
+1,493
| +6% | +$12.3K | ﹤0.01% | 3350 |
|
|
2021
Q4 | $364K | Buy |
+23,441
| New | +$364K | ﹤0.01% | 3217 |
|